Literature DB >> 7948742

Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells.

U Zorn1, I Dallmann, J Grosse, H Kirchner, H Poliwoda, J Atzpodien.   

Abstract

Soluble interleukin 2 receptors (sIL-2R) exert a potential role in immunoregulation. We investigated the in vitro effects of sIL-2R on several interleukin 2 (IL-2)-dependent cellular events. Cytotoxicity of human rIL-2-stimulated PBMC against K562 and Daudi was correlated inversely to the concentration of sIL-2R in the culture medium during rIL-2 stimulation. sIL-2R concentrations higher than 4.0 pM produced a significant loss of cytotoxicity (P < 0.01). The effect of different sIL-2R concentrations added to cultured human PBMC on secondary sIL-2R production was tested by ELISA. Secondary sIL-2R production was abrogated by high initial sIL-2R dosages whereas low initial dosages were followed by a continuing production of secondary sIL-2R after five days of culture. Proliferation of the IL-2-dependent mouse cell line CTLL-2-was suppressed by sIL-2R added to the culture medium in a dose-dependent way. The neutralizing capacity of sIL-2R strongly depended on the initial number of CTLL set in per proliferation assay. In contrast, variation of rIL-2-concentration had no significant effect on reduction of proliferation by sIL-2R. Furthermore, preincubation of sIL-2R with rIL-2 did not enhance growth suppression. These last findings indicate that there is at least no functional interaction between sIL-2R and free IL-2, whereas an interaction of sIL-2R with the membrane-bound receptor for IL-2 seems possible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948742     DOI: 10.1016/1043-4666(94)90058-2

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

Authors:  Dalil Hannani; Marie Vétizou; David Enot; Sylvie Rusakiewicz; Nathalie Chaput; David Klatzmann; Melanie Desbois; Nicolas Jacquelot; Nadège Vimond; Salem Chouaib; Christine Mateus; James P Allison; Antoni Ribas; Jedd D Wolchok; Jianda Yuan; Philip Wong; Michael Postow; Andrzej Mackiewicz; Jacek Mackiewicz; Dirk Schadendorff; Dirk Jaeger; Inka Zörnig; Jessica Hassel; Alan J Korman; Keith Bahjat; Michele Maio; Luana Calabro; Michele Wl Teng; Mark J Smyth; Alexander Eggermont; Caroline Robert; Guido Kroemer; Laurence Zitvogel
Journal:  Cell Res       Date:  2015-01-13       Impact factor: 25.617

3.  Neopterin serum levels in pancreatic adenocarcinoma.

Authors:  G Manes; O A Spada; P G Rabitti; B Feola; S Misso; A Minerva; G Uomo
Journal:  Int J Pancreatol       Date:  1999-02

4.  Effects of moderate endurance exercise and training on in vitro lymphocyte proliferation, interleukin-2 (IL-2) production, and IL-2 receptor expression.

Authors:  S G Rhind; P N Shek; S Shinkai; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

5.  Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer.

Authors:  Hui Li; Miaofang Wu; Zhuna Wu; Jinxiao Liang; Lijuan Wang; Xi Yang; Zhongqiu Lin; Jing Li
Journal:  Cancer Immunol Immunother       Date:  2021-11-01       Impact factor: 6.968

6.  Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous application.

Authors:  G I Kirchner; A Franzke; J Buer; W Beil; M Probst-Kepper; F Wittke; K Overmann; S Lassmann; R Hoffmann; H Kirchner; A Ganser; J Atzpodien
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

7.  Pretreatment serum markers and lymphocyte response to interleukin-2 therapy.

Authors:  L Fumagalli; P Lissoni; G Di Felice; S Meregalli; G Valsuani; S Mengo; F Rovelli
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Soluble IL-2Rα (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in mice.

Authors:  Shane E Russell; Anne C Moore; Padraic G Fallon; Patrick T Walsh
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.